[go: up one dir, main page]

WO2002032946A8 - Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae - Google Patents

Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae

Info

Publication number
WO2002032946A8
WO2002032946A8 PCT/EP2001/011983 EP0111983W WO0232946A8 WO 2002032946 A8 WO2002032946 A8 WO 2002032946A8 EP 0111983 W EP0111983 W EP 0111983W WO 0232946 A8 WO0232946 A8 WO 0232946A8
Authority
WO
WIPO (PCT)
Prior art keywords
polypeptides
basb207
haemophilus influenzae
polynucleotides
nontypeable haemophilus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2001/011983
Other languages
French (fr)
Other versions
WO2002032946A2 (en
WO2002032946A3 (en
Inventor
Joelle Thonnard
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to CA002426413A priority Critical patent/CA2426413A1/en
Priority to EP01987767A priority patent/EP1328541A2/en
Priority to AU2002220635A priority patent/AU2002220635A1/en
Publication of WO2002032946A2 publication Critical patent/WO2002032946A2/en
Publication of WO2002032946A3 publication Critical patent/WO2002032946A3/en
Publication of WO2002032946A8 publication Critical patent/WO2002032946A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention provides nontypeable Haemophilus influenzae BASB207 polypeptides and polynucleotides encoding BASB207 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are diagnostic, prophylactic and therapeutic uses, including vaccines against bacterial infections.
PCT/EP2001/011983 2000-10-17 2001-10-16 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae Ceased WO2002032946A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CA002426413A CA2426413A1 (en) 2000-10-17 2001-10-16 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae
EP01987767A EP1328541A2 (en) 2000-10-17 2001-10-16 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae
AU2002220635A AU2002220635A1 (en) 2000-10-17 2001-10-16 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0025488.8 2000-10-17
GBGB0025488.8A GB0025488D0 (en) 2000-10-17 2000-10-17 Novel compounds

Publications (3)

Publication Number Publication Date
WO2002032946A2 WO2002032946A2 (en) 2002-04-25
WO2002032946A3 WO2002032946A3 (en) 2002-10-31
WO2002032946A8 true WO2002032946A8 (en) 2003-01-09

Family

ID=9901500

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/011983 Ceased WO2002032946A2 (en) 2000-10-17 2001-10-16 Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae

Country Status (5)

Country Link
EP (1) EP1328541A2 (en)
AU (1) AU2002220635A1 (en)
CA (1) CA2426413A1 (en)
GB (1) GB0025488D0 (en)
WO (1) WO2002032946A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004009621A2 (en) * 2002-07-24 2004-01-29 Id Biomedical Corporation Polypeptides of nontypeable haemophilus influenzae

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2218741A1 (en) * 1995-04-21 1996-10-24 Human Genome Sciences, Inc. Nucleotide sequence of the haemophilus influenzae rd genome, fragments thereof, and uses thereof

Also Published As

Publication number Publication date
AU2002220635A1 (en) 2002-04-29
EP1328541A2 (en) 2003-07-23
WO2002032946A2 (en) 2002-04-25
WO2002032946A3 (en) 2002-10-31
CA2426413A1 (en) 2002-04-25
GB0025488D0 (en) 2000-11-29

Similar Documents

Publication Publication Date Title
WO1999058562A3 (en) Novel compounds
WO1999055873A3 (en) Basb006 polynucleotide(s) and polypeptides from neisseria meningitis
WO1999061620A3 (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
WO2000055327A3 (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
WO2002034768A3 (en) Polypeptides and polynucleodides from haemophilus influenzae and their use
WO2002032946A3 (en) Basb207 polypeptides and polynucleotides from nontypeable haemophilus influenzae
WO2002088361A3 (en) Haemophilus influenzae antigens
WO2000043519A3 (en) Neisseria meningitidis polypeptides
WO1999064602A3 (en) Moraxella catarrhalis polynucleotides and polypeptides
WO2002030971A3 (en) Basb205 polypeptides and polynucleotides coding therefor
WO2002024729A3 (en) Haemophilus influenzae basb202 polypeptide, production, vaccine and diagnostic use
WO2003055905A3 (en) Proteins of non typable haemophilus influenzae
WO2002030960A3 (en) Polypeptide from haemophilus influenza
WO2002034778A3 (en) Baseb209 polypeptides and polynucleotides from haemophilus influenzae
HK1047943A1 (en) Moraxella cattarrhalis basb114 antigens and uses thereof
WO2002100891A3 (en) Proteins derived from non-typable haemophilus influenzae (nthi) strain
WO2002079237A3 (en) Non-typeable haemophilus influenzae immunogenic polypeptides and use thereof
WO2000042191A3 (en) Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
WO2000071724A3 (en) Novel compounds from moraxella catarrhalis
WO2001009332A3 (en) Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof
WO2002088360A3 (en) Haemophilus influenzae antigens
WO2002066503A3 (en) H. influenzae antigen basb213
WO2002032945A3 (en) Haemophilus influenzae basb206 gene and protein
WO2002034772A3 (en) Novel compounds
WO2002060938A3 (en) Haemophilus influenza basb212 polynucleotides, polypeptides and use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page

Free format text: UNDER (57) PUBLISHED ABSTRACT REPLACED BY CORRECT ABSTRACT

WWE Wipo information: entry into national phase

Ref document number: 2426413

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2001987767

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2001987767

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Ref document number: 2001987767

Country of ref document: EP